Metoprolol adverse events and literature analyses: case/non-case analyses using the FDA Adverse Event Reporting System (FAERS)
This study identified unexpected signals of serious adverse reactions, suggesting the importance of continuous post-marketing surveillance of metoprolol to understand its potential risks.
Authors
- Weijian Liang
- Yi Du (ORCID: https://orcid.org/0000-0001-9568-0907)
- Mengting Zhang (ORCID: https://orcid.org/0009-0002-0301-4371)
- Chun Yang (ORCID: https://orcid.org/0000-0001-5813-0914)
- Jiahui Li (ORCID: https://orcid.org/0000-0002-9331-031X)
- Yin Huang (ORCID: https://orcid.org/0000-0001-9678-2630)
- Weichui Zhang (ORCID: https://orcid.org/0000-0001-8501-3588)
- Jiaqi Li (ORCID: https://orcid.org/0000-0001-6076-4350)
- Zhixin Chen
- Liang Zhang (ORCID: https://orcid.org/0000-0002-4056-9803)
- Jinfeng Zhu
- Ziyi Luo (ORCID: https://orcid.org/0009-0009-8363-5581)
- Mianda Hu
- Ronghao Fan
- Yi Liu (ORCID: https://orcid.org/0009-0003-6743-6415)
Institutions
- Guangdong Medical College (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Dongguan People’s Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1080/14740338.2024.2446420
- Citations
- 5
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Natural Science Foundation of Guangdong Province
- Research and Development